Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

April 01, 1999; 52 (7) Article

A controlled trial of recombinant methionyl human BDNF in ALS

The BDNF Study Group (Phase III)
First published April 1, 1999, DOI: https://doi.org/10.1212/WNL.52.7.1427
Full PDF
Citation
A controlled trial of recombinant methionyl human BDNF in ALS
The BDNF Study Group (Phase III)
Neurology Apr 1999, 52 (7) 1427; DOI: 10.1212/WNL.52.7.1427

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1139

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 52 no. 7 1427
DOI: 
https://doi.org/10.1212/WNL.52.7.1427
PubMed: 
10227630

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received March 16, 1998
  • Accepted in final form January 9, 1999
  • First Published April 1, 1999.

Copyright & Usage: 
© 1999

Author Disclosures

    1. The BDNF Study Group (Phase III)*
  1. The BDNF Study Group (Phase III)*
  1. Address correspondence and reprint requests to Dr. Walter G. Bradley, Department of Neurology (D4-5), University of Miami School of Medicine, P.O. Box 016960, Miami, FL 33101.
View Full Text

Article usage

Article usage: October 2000 to May 2023

AbstractFullPdfSource
Oct 2000132Highwire
Nov 20009186Highwire
Dec 2000380Highwire
Jan 2001184Highwire
Feb 2001163Highwire
Mar 2001086Highwire
Apr 2001154Highwire
May 20015152Highwire
Jun 2001362Highwire
Jul 2001299Highwire
Aug 2001283Highwire
Sep 2001030Highwire
Oct 20011104Highwire
Nov 200111110Highwire
Dec 2001232Highwire
Jan 2002240Highwire
Feb 2002483Highwire
Mar 20024133Highwire
Apr 20022168Highwire
May 20020112Highwire
Jun 20022114Highwire
Jul 2002083Highwire
Aug 2002278Highwire
Sep 20021137Highwire
Oct 20024124Highwire
Nov 20021136Highwire
Dec 20022912Highwire
Jan 2003283Highwire
Feb 20034108Highwire
Mar 2003142Highwire
Apr 2003394Highwire
May 200331610Highwire
Jun 20032166Highwire
Jul 2003162913Highwire
Aug 20039101Highwire
Sep 20038156Highwire
Oct 20033168Highwire
Nov 20037134Highwire
Dec 2003483Highwire
Jan 200410167Highwire
Feb 20041104Highwire
Mar 20049103Highwire
Apr 200410225Highwire
May 200410177Highwire
Jun 200413273Highwire
Jul 200411323Highwire
Aug 200418171Highwire
Sep 20048192Highwire
Oct 20046164Highwire
Nov 200461311Highwire
Dec 20046216Highwire
Jan 200518238Highwire
Feb 20058244Highwire
Mar 200511293Highwire
Apr 200511408Highwire
May 20059205Highwire
Jun 20058222Highwire
Jul 200510130Highwire
Aug 200510222Highwire
Sep 20054231Highwire
Oct 200584010Highwire
Nov 20054282Highwire
Dec 20058103Highwire
Jan 2006896Highwire
Feb 20061163Highwire
Mar 2006682Highwire
Apr 2006151Highwire
May 2006774Highwire
Jun 2006442Highwire
Jul 2006656Highwire
Aug 2006131Highwire
Sep 20061143Highwire
Oct 2006344Highwire
Nov 2006365Highwire
Dec 20061064Highwire
Jan 2007437Highwire
Feb 2007734Highwire
Mar 2007394Highwire
Apr 2007584Highwire
May 2007964Highwire
Jun 2007823Highwire
Jul 20071052Highwire
Aug 2007631Highwire
Sep 2007812Highwire
Oct 2007171110Highwire
Nov 2007843Highwire
Dec 20071354Highwire
Jan 20081757Highwire
Feb 20081687Highwire
Mar 200814156Highwire
Apr 20081972Highwire
May 200826124Highwire
Jun 200813104Highwire
Jul 20081978Highwire
Aug 20082543Highwire
Sep 20081532Highwire
Oct 20081764Highwire
Nov 20081463Highwire
Dec 20081443Highwire
Jan 2009953Highwire
Feb 20092255Highwire
Mar 20092666Highwire
Apr 20093176Highwire
May 20093355Highwire
Jun 20091879Highwire
Jul 200991412Highwire
Aug 20091364Highwire
Sep 20091268Highwire
Oct 20092745Highwire
Nov 20092841Highwire
Dec 20091353Highwire
Jan 20101741Highwire
Feb 20102185Highwire
Mar 20102064Highwire
Apr 20101733Highwire
May 2010811Highwire
Jun 20101224Highwire
Jul 2010934Highwire
Aug 2010201010Highwire
Sep 20101232Highwire
Oct 20101312Highwire
Nov 20101212Highwire
Dec 20101033Highwire
Jan 20111553Highwire
Feb 20111744Highwire
Mar 20112096Highwire
Apr 201121136Highwire
May 20112614Highwire
Jun 20111643Highwire
Jul 20111344Highwire
Aug 20111501Highwire
Sep 201116510Highwire
Oct 201116179Highwire
Nov 20111103Highwire
Dec 2011673Highwire
Jan 20121500Highwire
Feb 20121733Highwire
Mar 20121333Highwire
Apr 20121444Highwire
May 20122965Highwire
Jun 20122023Highwire
Jul 20122255Highwire
Aug 2012744Highwire
Sep 2012731Highwire
Oct 20121421Highwire
Nov 201212149Highwire
Dec 2012900Highwire
Jan 20132211Highwire
Feb 20131646Highwire
Mar 20131731Highwire
Apr 20132143Highwire
May 20131862Highwire
Jun 20131055Highwire
Jul 20131722Highwire
Aug 20131585Highwire
Sep 20131442Highwire
Oct 20132723Highwire
Nov 20131432Highwire
Dec 20132400Highwire
Jan 20143184Highwire
Feb 20143433Highwire
Mar 20142653Highwire
Apr 20141233Highwire
May 20143133Highwire
Jun 20142154Highwire
Jul 20142363Highwire
Aug 20141341Highwire
Sep 2014643Highwire
Oct 20142033Highwire
Nov 20141343Highwire
Dec 20143634Highwire
Jan 20151744Highwire
Feb 20152410Highwire
Mar 20151923Highwire
Apr 2015523Highwire
May 20151913Highwire
Jun 20152613Highwire
Jul 20153010Highwire
Aug 20152155Highwire
Sep 20152121Highwire
Oct 20152243Highwire
Nov 20152311Highwire
Dec 20151932Highwire
Jan 20162701Highwire
Feb 20163922Highwire
Mar 20161833Highwire
Apr 20164034Highwire
May 20165631Highwire
Jun 20162621Highwire
Jul 2016921Highwire
Aug 20161812Highwire
Sep 20162800Highwire
Oct 20162801Highwire
Nov 20161600Highwire
Dec 20161343Highwire
Jan 20173257Highwire
Feb 20172511Highwire
Mar 20172523Highwire
Apr 20171401Highwire
May 20171521Highwire
Jun 20171830Highwire
Jul 20171432Highwire
Aug 20171241Highwire
Sep 20171401Highwire
Oct 20171901Highwire
Nov 2017801Highwire
Dec 20172200Highwire
Jan 20184202Highwire
Feb 20183734Highwire
Mar 20182374Highwire
Apr 20182563Highwire
May 20183032Highwire
Jun 20183603Highwire
Jul 20181412Highwire
Aug 20183663Highwire
Sep 20183814Highwire
Oct 20182433Highwire
Nov 20184733Highwire
Dec 20183413Highwire
Jan 20192712Highwire
Feb 20192633Highwire
Mar 20193122Highwire
Apr 20194893Highwire
May 20194412Highwire
Jun 20193011Highwire
Jul 20193856Highwire
Aug 20193336Highwire
Sep 20193173Highwire
Oct 20194665Highwire
Nov 20193913Highwire
Dec 20192622Highwire
Jan 20202013Highwire
Feb 20204125Highwire
Mar 20203108Highwire
Apr 20205227Highwire
May 20202932Highwire
Jun 20201923Highwire
Jul 20203328Highwire
Aug 20203614Highwire
Sep 202095610Highwire
Oct 20207066Highwire
Nov 20204036Highwire
Dec 20208918Highwire
Jan 20213883Highwire
Feb 20212974Highwire
Mar 20213524Highwire
Apr 20212435Highwire
May 20217548Highwire
Jun 20214946Highwire
Jul 20213864Highwire
Aug 20214936Highwire
Sep 202144312Highwire
Oct 202170515Highwire
Nov 20215105Highwire
Dec 202156311Highwire
Jan 20226408Highwire
Feb 202292210Highwire
Mar 202280013Highwire
Apr 20225367Highwire
May 202258110Highwire
Jun 20223816Highwire
Jul 20226309Highwire
Aug 202264421Highwire
Sep 20224318Highwire
Oct 202289313Highwire
Nov 20225563Highwire
Dec 202211003Highwire
Jan 20237421Highwire
Feb 20238866Highwire
Mar 202368617Highwire
Apr 20234958Highwire
May 20236811Highwire

Cited By...

  • 387 Citations
  • Google Scholar

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Appendix
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post Hoc Analysis of the EXTEND-IA TNK Trials

Dr. Nicole Sur and Dr. Mausaminben Hathidara

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    New approaches to the treatment of ALS
    Robert G. Miller, Robert Sufit et al.
    Neurology, April 01, 1997
  • Articles
    A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis
    ALS CNTF Treatment Study Group et al.
    Neurology, May 01, 1996
  • Clinical Trials and Future Research
    Clinical trials of riluzole in patients with ALS
    R. G. Miller, J. P. Bouchard, P. Duquette et al.
    Neurology, October 01, 1996
  • Articles
    Clinical evaluation of ALS drugs
    Benjamin Rix Brooks et al.
    Neurology, April 01, 1997
Neurology: 100 (23)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise